Dr. Stegmaier has advanced the application of genomics to drug and protein target discovery for childhood cancers. She is the vice chair for Pediatric Oncology Research, co-director of the Pediatric Hematologic Malignancy Program and a pediatric oncologist at the Dana-Farber Cancer Institute and Boston Children’s Hospital, and an institute member of the Broad Institute. She has served as a council member with the Society for Pediatric Research and as chair of the American Association for Cancer Research Pediatric Cancer Working Group. Dr. Stegmaier was the recipient of the Joanne Levy, MD, Memorial Award for Outstanding Achievement from the American Society of Hematology, a Stand Up To Cancer (SU2C) Innovative Research Grant, the E. Mead Johnson Award for Research in Pediatrics, and an NCI Outstanding Investigator Award. She was elected to the American Society of Clinical Investigation and the Association of American Physicians. Dr. Stegmaier received her undergraduate degree from Duke University where she graduated valedictorian, medical degree from Harvard Medical School, and trained in pediatrics and pediatric hematology/oncology at Boston Children’s Hospital and Dana-Farber Cancer Institute.